ImmunoCellular Therapeutics, Ltd. (NYSE MKT: IMUC) is an emerging leader in the research, development and commercialization of novel cancer immunotherapies for the treatment brain, ovarian and other solid tumors.
http://www.imuc.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Sunday
LOAD TIME
0.3 seconds
16x16
32x32
64x64
128x128
160x160
192x192
256x256
Questa Gleason
23622 ●●●●●●as Rd.
Sui●●●300
Cal●●●asa , California, 91302
United States
View this contact
Questa Gleason
23622 ●●●●●●as Rd.
Sui●●●300
Cal●●●asa , California, 91302
United States
View this contact
Questa Gleason
23622 ●●●●●●as Rd.
Sui●●●300
Cal●●●asa , California, 91302
United States
View this contact
BUY YOUR DOMAIN
23
YEARS
4
MONTHS
21
DAYS
GODADDY.COM, LLC
WHOIS : whois.godaddy.com
REFERRED : http://registrar.godaddy.com
PAGES IN
THIS WEBSITE
11
SSL
EXTERNAL LINKS
122
SITE IP
198.55.244.7
LOAD TIME
0.275 sec
SCORE
6.2
Immunocellular Therapeutics’ work in industry-leading, next-generation cancer immunotherapies | imuc.com Reviews
https://imuc.com
ImmunoCellular Therapeutics, Ltd. (NYSE MKT: IMUC) is an emerging leader in the research, development and commercialization of novel cancer immunotherapies for the treatment brain, ovarian and other solid tumors.
Investor Relations - ImmunoCellular
April 14, 2015 - CEO Andrew Gengos interview with The Wall Street Analyzer. August 13, 2015. ImmunoCellular Therapeutics Reaches Agreement with FDA on Special Protocol Assessment (SPA) for ICT-107 Phase 3 Registrational Trial in Glioblastoma. August 6, 2015. ImmunoCellular Therapeutics Announces Second Quarter 2015 Financial Results. View all press releases ». August 6, 2015 at 2:00 PM PT. ImmunoCellular Therapeutics Second Quarter 2015 Financial Results. July 8, 2015 at 2:30 PM ET.
imuc.com
Timeline History of ImmunoCellular Therapeutics
http://www.imuc.com/about-us/immunocellular-history
ImmunoCellular Therapeutics was established in 2006 with cellular-based technology licensed from the Cedars-Sinai Medical Center in Los Angeles. In 2012, ImmunoCellular Therapeutics was listed under the symbol IMUC on the New York Stock Exchange.
ICT-170 Frequently Asked Questions
http://www.imuc.com/pipeline/ict-107/ict-107-faq
1 What is ICT-107? ICT-107 is an autologous (patient-derived) dendritic cell (DC) immunotherapy that targets six different antigens (peptides that are tumor markers: AIM-2, MAGE-1, TRP-2, gp100, HER-2, IL-13Ra2) associated with glioblastoma, a form of brain cancer. At least four of these tumor-associated antigens are highly expressed on cancer stem cells (CSCs). ICT-107 is designed for use following surgical tumor resection of newly diagnosed glioblastoma in combination with standard treatment of...ICT-1...
ImmunoCellular Therapeutics Management Team bios
http://www.imuc.com/about-us/management
President, Chief Executive Officer and Director. Mr Gengos joined ImmunoCellular Therapeutics in December 2012. Spanning more than 20 years in the life science industry, his experience includes executive leadership positions in both large and emerging companies. He has broad expertise in corporate strategy, business development and transactions, including mergers and acquisitions, financing, operations, commercial planning and healthcare policy. John S. Yu, M.D.,. Anthony J. Gringeri, Ph.D,.
Business Development for ImmunoCellular Therapeutics’ proprietary cancer vaccine technology
http://www.imuc.com/business-development
ImmunoCellular Therapeutics aspires to be an industry-leading, independent, immunotherapy company serving patients with cancer. ImmunoCellular believes that the company’s proprietary cancer immunotherapy technology platform is broadly enabling, with the potential to generate many immunotherapeutic products that can improve cancer treatment and bring meaningful benefit to patients and their families. As ImmunoCellular’s clinical pipeline advances, strategic investments will position the company for ...
Overview of ImmunoCellular Therapeutics’ dendritic cell (DC) vaccine ICT-107
http://www.imuc.com/pipeline/ict-107
ICT-107 is a dendritic cell (DC) vaccine for the treatment of newly diagnosed glioblastoma multiforme (GBM), the most common and lethal type of brain cancer. ICT-107 is designed to activate a patient’s immune system to target six different tumor-associated antigens. ICT-107 has been granted orphan drug designation in the US and Europe. For patients, families and physicians seeking additional information about the ICT-107 phase 3 trial, please consult www.clinicaltrials.gov/ct2/show/NCT02546102?
TOTAL PAGES IN THIS WEBSITE
11
May | 2012 | Dingler Weblog
https://dinglerweblog.wordpress.com/2012/05
Archive for May, 2012. WSPR Szczecin, Largest Polish EMS Agency Adds ZOLL’s Integrated Automated Compression-Defibrillation System. Thursday, May 31st, 2012. ZOLL Medical Corporation Posted on:29 Nov 11 ZOLL Medical Corporation (Nasdaq GS: ZOLL), a manufacturer of medical devices and related software solutions, announced today that Wojewódzka Stacja Pogotowia Ratunkowego Szczecin ( WSPR Szczecin ), the largest emergency service operator in Poland, is equipping its ambulances with a revolutionary new syst...
Investor Relations - ImmunoCellular
http://investors.imuc.com/index.cfm
November 2, 2016. ImmunoCellular Therapeutics to Report Third Quarter 2016 Financial Results on November 10, 2016. August 22, 2016. ImmunoCellular Therapeutics Announces Second Quarter 2016 Financial Results. View all press releases ». November 10, 2016 at 2:00 PM PT. ImmunoCellular Therapeutics Third Quarter 2016 Financial Results. View all events and presentations ».
Committee Composition - ImmunoCellular
http://investors.imuc.com/committees.cfm
Show all ». Gary S. Titus. Chair of the Audit Committee. Member of the Compensation Committee. Member of the Finance Committee. Rahul Singhvi, Sc.D., MBA. Member of the Audit Committee. Chair of the Nominating and Governance Committee. Chair of the Finance Committee. John S. Yu, M.D. Gregg A. Lapointe. Chair of the Compensation Committee. Mark A. Schlossberg. Member of the Audit Committee. Member of the Nominating and Governance Committee. Gary S. Titus. Rahul Singhvi, Sc.D., MBA. Gregg A. Lapointe.
Events & Presentations - ImmunoCellular
http://investors.imuc.com/eventdetail.cfm?EventID=162299
Details on this event are not available.
Shareholder Briefcase - ImmunoCellular
http://investors.imuc.com/briefcase.cfm
Collect, zip and download files from our Investor Relations website. Click on the briefcase icon. Located near most downloadable files throughout our IR website and use this page to manage your briefcase. You currently have no files in your Shareholder Briefcase.
Events & Presentations - ImmunoCellular
http://investors.imuc.com/events.cfm
Details on upcoming events are not yet available. August 22, 2016. ImmunoCellular Therapeutics Second Quarter 2016 Financial Results. LIVE CALL: (877) 853-5636 (toll-free); international dial-in: (631) 291-4544; conference code 67085549. June 2, 2016. 2016 Marcum Microcap Conference. May 12, 2016. ImmunoCellular Therapeutics First Quarter 2016 Financial Results. Speaker: Andrew Gengos, CEO. LIVE CALL: (877) 853-5636 (toll-free); international dial-in: (631) 291-4544; conference code 5791130.
SEC Filings - ImmunoCellular
http://investors.imuc.com/sec.cfm
All Filings (excluding Section 16). November 4, 2016. October 4, 2016. Definitive additional proxy materials. October 4, 2016. September 23, 2016. September 16, 2016. September 1, 2016. August 22, 2016. August 22, 2016. August 16, 2016. Notification of late filing. August 11, 2016. 10 results per page. 25 results per page. 50 results per page. Add PDF file to Briefcase.
Analyst Coverage - ImmunoCellular
http://investors.imuc.com/analysts.cfm
ImmunoCellular is covered by the following analysts. Please note that any opinions, estimates or forecasts regarding ImmunoCellular's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of ImmunoCellular or its management. ImmunoCellular does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.
ImmunoCellular Therapeutics Reaches Agreement with FDA on Special Protocol Assessment (SPA) for ICT-107 Phase 3 Registrational Trial in Glioblastoma (NYSE:IMUC)
http://investors.imuc.com/releasedetail.cfm?ReleaseID=927519
August 13, 2015. Laquo; Previous Release. Next Release ». ImmunoCellular Therapeutics Reaches Agreement with FDA on Special Protocol Assessment (SPA) for ICT-107 Phase 3 Registrational Trial in Glioblastoma. Aug 13, 2015. PRNewswire/ - ImmunoCellular Therapeutics, Ltd. (". NYSE MKT: IMUC) announced today that it has reached agreement with the. US Food and Drug Administration. And the EU. The primary endpoint in the trial is overall survival, which the. On the design, clinical endpoints, size and statisti...
TOTAL LINKS TO THIS WEBSITE
122
IGREJA MISSIONÁRIA UNIDA PENIEL
SE LIGA NA INFORMAÇÃO. Quarta-feira, 6 de abril de 2011. Oração venha participar toda sexta-feira Jovens e Adolescentes. APRENDENDO A SER UM VERDADEIRO DISCIPULO. Compartilhar com o Pinterest. Escrito por IMUB PORTO VELHO-RO. FOTOS DA GALERA DA IMUP. Conheça aqui os Locais! Acompanhe os locais dos grupos familiares. Igreja Missionária Unida Peniel. Imagens de modelo por fpm.
IMUBrasil
Esqueci a minha senha. Reenviar confirmação de cadastro. Vários irmãos da IMUB já estão reunidos nessa comunidade! Você conhece algum desses? Clique na foto para ampliar). Porque, onde estiverem dois ou três reunidos em meu nome, ali estou no meio deles".
:: MUBS방송국 홈페이지에 오신것을 환영합니다. 즐거운시간 되세요. ^^ ::
MUBS방송국 홈페이지에 오신것을 환영합니다. 즐거운시간 되세요. 종방안내] 2017년 12월 12일부터. 휴방안내] 10월 16일부터 20일까. 휴방안내] 10월 2일부터 9일까지. 휴방안내] 9월 26일부터 28일까. MUBS 캠페인 - 저. MUBS 캠페인 - 이. How Deep Is Your Love. 에이프릴 - 파랑새 신청합니다. 골든차일드 - 너라고 신청합니다. 삭제를 원하시면 왼쪽에 한줄신청곡 베너를 눌러주세요 -. 170913] MNU NEWS . 170906] MNU NEWS . MUBS방송국 홈페이지에 오신것을 환영합니다. 즐거운시간 되세요. MUBS방송국 홈페이지에 오신것을 환영합니다. 즐거운시간 되세요. 남도 다도해 문화관광 사업단.
Imub Teens Campinas
Seja bem vindo ao blog da Imub teens, que Deus te abençoe! Postado por Imub Teens Campinas. Comunhão, uma palavra tão usada no Mundo, uma palavra que para muitos é comum, mais uma palavra que é essencial ser exercida para que nós possamos crescer na vida, ser alguém. Mas muitas pessoas fazem um ‘’teatro’’ sobre viver em comunhão, ou não sabem o verdadeiro significado (ou fingem não saber). Com alguém ‘estranho’? E é assim todos os dias,em todos os lugares, em todas as. Rodinhas , sempre tem um. Frequenta...
imubuddhistsociety.blogspot.com
IMU Buddhist Society
International Medical University, Malaysia. Sunday, March 24, 2013. Meditation Class: Mindfulness of Feelings. Have you ever experienced that your decisions are manipulated by emotions? On 28th March 2013, from 7.30pm to 9.30 pm, IMUBS will be organising a meditation class on the title "Mindfulness Of Feelings". The venue is at MPH5. Everyone is invited to explore and understand more about their feelings through this meditation class. Do come and support us! Sunday, March 24, 2013. Tuesday, March 12, 2013.
Immunocellular Therapeutics’ work in industry-leading, next-generation cancer immunotherapies
March 13, 2018 - ImmunoCellular Therapeutics Fourth Quarter 2017 Conference Call and Webcast. Monday, March 26, 2018. ImmunoCellular Therapeutics Receives Audit Opinion with Going Concern Explanation read more . Tuesday, March 13, 2018. ImmunoCellular Therapeutics Announces Fourth Quarter and Full Year 2017 Financial Results read more . Wednesday, March 7, 2018. ImmunoCellular Therapeutics to Report Fourth Quarter and Full Year 2017 Financial Results read more .
Interessenverband Musikmanager & Consultants e.V. (IMUC) |
Aufklären. Fördern. Vertreten. Are you ready for Frankfurt? 8211; Kreatives FrankfurtRheinMain. Are you ready for Frankfurt? 8211; Kreatives FrankfurtRheinMain … ein toller Film des Clusters der Kreativwirtschaft in Hessen e.V. (Cluk), der die Vielfalt der Kreativwirtschaft in FrankfurtRheinMain auf den Punkt bringt. IMUC ist übrigens Gründungsmitglied. IMUC wieder auf dem Reeperbahnfestival 2017. Meilenstein für Musikurheber: GEMA und YouTube unterzeichnen Lizenzvertrag. Laquo; Ältere Einträge. Der Inte...
Price Request - BuyDomains
Url=' escape(document.location.href) , 'Chat367233609785093432', 'toolbar=0,scrollbars=0,location=0,statusbar=0,menubar=0,resizable=0,width=640,height=500');return false;". Need a price instantly? Just give us a call. Toll Free in the U.S. We can give you the price over the phone, help you with the purchase process, and answer any questions. Get a price in less than 24 hours. Fill out the form below. One of our domain experts will have a price to you within 24 business hours. United States of America.
Home
The Crown Forces Form Square to fend off cavalry at The Battle of Chippewa/Lundy's Lane event in 2014. Life in the encampment. a respite from battle and a place to rest, chat, and relax. Marching steady onto the field for another battle. The Incorporated Militia is on the way! As night falls in Fort Erie, the line fires a volley at the dreaded invaders in the fort! At the Annual Mess Dinner, there's always time to have a dance and create memories. Contact us via email. How To Join IMUC. We invite you, th...
IMUC | Bine ati venit!
SC IMUC S.A. a luat fiinta in anul 1960 ca filiala a Trustului de Montaj Utilaj Chimic Bucuresti, TMUCB din care s-a desprins in anul 1991, constituindu-se ca societate cu capital privat si inregistrata in Registrul Camerei de Comert Pitesti cu nr.J.03/236 vol.II 1991 pentru activitati in tara si in strainatate. Sudate , sisteme de conducte , rezervoare cilindrice si sferice. Experienta si realizarile din cei 51 ani de activitate arata ca IMUC PITESTI SA este un partener a carui seriozitate este. Contrac...
Купить духи, туалетную воду, парфюмению и косметику по низким ценам – интернет-магазин Imuc
Звонок по России бесплатный. Бижутерия из титана Cassinie UNISEX. Подарки на 8 Марта. Подарки на новый год. Duty Free через интернет. Аромагороскоп: выбор духов по знаку зодиака. Fahrenheit, 100 ml (Christian Dior). Amor Amor, 100 ml (Cacharel). CK Free, 100 ml (Calvin Klein). Happy in Red, 100 ml (Armand Basi). Black XS L`exces, 100ml (Paco Rabanne). 212 VIP Rose, 80 ml (Carolina Herrera). Play, 100 ml (Givenchy). La Vie Est Belle, 75 ml (Lancome). SP) Тушь Mascara Singulier, 12ml (Roberto Cavalli).
SOCIAL ENGAGEMENT